NCT03233711 2026-03-18
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
12 trialsNCT06958328 2026-02-02
LAP100
NRG Oncology
Phase 3 Recruiting
NCT03533582 2025-12-22
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
Children's Oncology Group
Phase 3 Active not recruiting
NCT02135419 2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3 Completed
NCT02355379 2024-07-08
ADAGE
Federation Francophone de Cancerologie Digestive
Phase 3 Recruiting
NCT06313567 2024-07-08
Metronomic Capecitabine in Stage III Gastric Cancer
Fudan University
Phase 3 Recruiting
NCT02109146 2024-05-29
Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma
Zhejiang University
Phase 3 Completed
NCT03199989 2020-03-06
EPAC1
Peking University Cancer Hospital & Institute
Phase 3 Unknown
NCT00759109 2017-04-07
Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00442637 2013-12-12
CAIRO3
Dutch Colorectal Cancer Group
Phase 3 Unknown
NCT00566644 2013-07-10
Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00427310 2013-01-03
Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery
NSABP Foundation Inc
Phase 3 Completed